S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7134 +0.18%
PRE-MKT · 05:00 ET
Market ClerkRecap
Fri Oct 23 · pre-market6 signals on Oct 22103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead
KJ
INSIDER · AMLX · Amylyx Pharmaceuticals, Inc. · CO-CHIEF EXECUTIVE OFFICER

Klee Justin B.

Every open-market transaction filed under this name, Sep 10 to Sep 10.

Filings
2
0 buys · 2 sells
Bought
—
open market, at cost
Sold
$980K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 10AMLXAmylyx Pharmaceuticals, Inc.Co-Chief Executive OfficerSell1,439$33.16$48K—
Sep 10AMLXAmylyx Pharmaceuticals, Inc.Co-Chief Executive OfficerSell29,025$32.13$933K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.